These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30209612)

  • 1. Modified AJCC staging of gastric neuroendocrine carcinoma based on T staging can improve the capacity of prognosis assessment.
    Xie JW; Li P; Wang JB; Lin JX; Lu J; Chen QY; Yang YH; Kang DY; Zheng CH; Huang CM
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2391-2397. PubMed ID: 30209612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified staging system for gastric neuroendocrine carcinoma based on American Joint Committee on Cancer and European Neuroendocrine Tumor Society systems.
    Lu J; Zhao YJ; Zhou Y; He Q; Tian Y; Hao H; Qiu X; Jiang L; Zhao G; Huang CM;
    Br J Surg; 2020 Feb; 107(3):248-257. PubMed ID: 31971627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma.
    Wang H; Lin Z; Li G; Zhang D; Yu D; Lin Q; Wang J; Zhao Y; Pi G; Zhang T
    BMC Cancer; 2020 Mar; 20(1):188. PubMed ID: 32138704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma.
    Xu B; Chu Y; Hu Q; Song Q
    Technol Cancer Res Treat; 2021; 20():15330338211055340. PubMed ID: 34806493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
    Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
    Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel staging for gastric neuroendocrine neoplasms by incorporating the WHO grading into the TNM staging system.
    Zhang R; Guo Y; Wang Y; Hu L; Fang C; Yang Y; Yang X; Chen L; Chen J; Wang W; Sun X
    Cancer Med; 2023 Mar; 12(6):6623-6636. PubMed ID: 36394081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equipping the 8th Edition American Joint Committee on Cancer Staging for Gastric Cancer with the 15-Node Minimum: a Population-Based Study Using Recursive Partitioning Analysis.
    Yuan SQ; Chen YT; Huang ZP
    J Gastrointest Surg; 2017 Oct; 21(10):1591-1598. PubMed ID: 28752402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of seventh edition AJCC gastric cancer staging modifications.
    Kim DH; Oh CA; Oh SJ; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    J Surg Oncol; 2012 Jan; 105(1):26-30. PubMed ID: 21761411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which staging system better predicts 10-year survival for gastric cancer? A study using an international multicenter database.
    Lin JX; Lin JP; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Huang CM
    Eur J Surg Oncol; 2018 Aug; 44(8):1205-1211. PubMed ID: 29804693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends of incidence and prognosis of gastric neuroendocrine neoplasms: a study based on SEER and our multicenter research.
    Hu P; Bai J; Liu M; Xue J; Chen T; Li R; Kuai X; Zhao H; Li X; Tian Y; Sun W; Xiong Y; Tang Q
    Gastric Cancer; 2020 Jul; 23(4):591-599. PubMed ID: 32026156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation of a modified 8th AJCC TNM system for advanced gastric cancer: Long-term results in southern China.
    Ye J; Ren Y; Wei Z; Hou X; Dai W; Cai S; Tan M; He Y; Yuan Y
    Surg Oncol; 2018 Jun; 27(2):146-153. PubMed ID: 29937164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel TNM staging system for gastric cancer based on the metro-ticket paradigm: a comparative study with the AJCC-TNM staging system.
    Lu J; Zheng ZF; Wang W; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Zhou ZW; Huang CM; Zheng CH; Li P
    Gastric Cancer; 2019 Jul; 22(4):759-768. PubMed ID: 30612230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A better prognostic stratification for the 8th edition of the AJCC staging system of gastric cancer by incorporating pT4aN0M0 into stage IIIA.
    Chen Y; Zhang G; Zhao B; Huang C; Ling Y; Li Y; Zhou Z
    Surg Oncol; 2019 Jun; 29():90-96. PubMed ID: 31196500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of the 8th American Joint Committee on Cancer staging system for gallbladder carcinoma to improve prognostic precision.
    Jiang W; Zhao B; Li Y; Qi D; Wang D
    BMC Cancer; 2020 Nov; 20(1):1129. PubMed ID: 33225924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer.
    Abdel-Rahman O
    Clin Transl Oncol; 2018 Apr; 20(4):550-556. PubMed ID: 28808860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of AJCC TNM Staging 7th edition in limited-stage small cell lung cancer: validation in 437 patients].
    Zhang W; Zhu H; Zhou Z; Feng Q; Chen D; Zhang H; Xiao Z; Wang L
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):917-22. PubMed ID: 26887621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting Dukes' paradigm; some node positive colon cancer patients have better prognosis than some node negative patients.
    Abdel-Rahman O
    Clin Transl Oncol; 2018 Jun; 20(6):794-800. PubMed ID: 29086248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the 8th Edition of the AJCC TNM Staging System Sufficiently Reasonable for All Patients with Noncardia Gastric Cancer? A 12,549-Patient International Database Study.
    Lu J; Zheng ZF; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang CM; Zheng CH; Li P
    Ann Surg Oncol; 2018 Jul; 25(7):2002-2011. PubMed ID: 29725896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the AJCC TNM staging system still appropriate for gastric cancer patients survival after 5 years?
    Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM; Li P
    Eur J Surg Oncol; 2019 Jun; 45(6):1115-1120. PubMed ID: 30661920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8
    Chen HY; Wang X; Zhang H; Liu XB; Tan CL
    World J Gastroenterol; 2019 Dec; 25(46):6752-6766. PubMed ID: 31857777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.